Publications
5530 Results
- Journal / Conference
- ASCO 8:257(#1001)
- Year
- 1989
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14
Long-term followup of patients with low grade lymphoma treated with CHOP ( cyclophosphamide, doxorubicin, vincristine, prednisone)-based chemotherapy or chemoimmunotherapy on Southwest Oncology Group studies
- Journal / Conference
- ASCO 8:257(#1003)
- Year
- 1989
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14
Long-term survival of patients with nodular histiocytic (NH),diffuse poorly differentiated lymphocytic (DPDL), diffuse mixed (DM),and diffuse undifferentiated (DU) lymphoma treated with CHOP chemotherapy.
- Journal / Conference
- ASCO 8:24(#89)
- Year
- 1989
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7436
Adjuvant combination chemotherapy (CMFVP) vs L-phenylalanine mustard (LPAM) for operable breast cancer with positive axillary lymph nodes: 10 year results.
- Journal / Conference
- ASCO 8:320(#1244)
- Year
- 1989
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-7440
Long term followup in the cure of osteogenic sarcoma.
- Journal / Conference
- ASCO 8:107(#415)
- Year
- 1989
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7510
After resection of large bowel carcinoma, immune status is often depressed. Data from a SWOG study.
- Journal / Conference
- ASCO 8:90(#352)
- Year
- 1989
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-7703
A retrospective comparison of high dose BCNU with autologous marrow rescue plus radiotherapy vs. IV BCNU plus radiation therapy in high grade gliomas: A Southwest Oncology Group review.
- Journal / Conference
- ASCO 8:253(#987)
- Year
- 1989
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7808
Efficacy of low dose involved field (LDIF) XRT in producing and maintaining CR following PR induction with MOP-BAP chemotherapy in hodgkin's disease, results of Southwest Oncology Group study 7808
- Journal / Conference
- ASCO 8:24(#88)
- Year
- 1989
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7827
Adjuvant chemotherapy for poor prognosis estrogen receptor negative stage II-III breast cancer; a comparison of one year vs two years CMFVP.
- Journal / Conference
- ASCO 8:203(#790)
- Year
- 1989
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-7984
A stratified, randomized trial of busulfan (B) or busulfan plus vitamin A (BVA) for the management of chronic myelogenous leukemia(CML).
- Journal / Conference
- ASCO 8:134(#522)
- Year
- 1989
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8110